Sage View Care Center in Rock Springs, WY - Skilled Nursing Facility

Sage View Care Center is a Skilled Nursing Facility based in Rock Springs, Wyoming. Sage View Care Center is licensed to practice in * (Not Available) (license number ) and their current practice location is 1325 Sage St, Rock Springs, Wyoming. It can be reached at their office (for appointments etc.) via phone at (307) 362-3780.

NPI number for Sage View Care Center is 1265146443 and their current mailing address is 1777 Avenue Of The States Ste 102, Lakewood, New Jersey. Sage View Care Center does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1265146443.

Contact Information

	Sage View Care Center
	1325 Sage St, Rock Springs, WY 82901-7478
	(307) 362-3780
	Not Available

Healthcare Provider's Profile

Full Name	Sage View Care Center
Type	Facility
Speciality	Skilled Nursing Facility
Location	1325 Sage St, Rock Springs, Wyoming
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1265146443
Provider Enumeration Date: 01/11/2023
Last Update Date: 09/17/2023

Medical Identifiers

Medical identifiers for Sage View Care Center such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265146443	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	(* (Not Available))	Secondary
225X00000X	Occupational Therapist	(* (Not Available))	Secondary
235Z00000X	Speech-language Pathologist	(* (Not Available))	Secondary
314000000X	Skilled Nursing Facility	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sage View Care Center is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sage View Care Center 1777 Avenue Of The States Ste 102, Lakewood, NJ 08701-4779 Ph: (732) 366-8300	Sage View Care Center 1325 Sage St, Rock Springs, WY 82901-7478 Ph: (307) 362-3780

News Archive

Study links high-fat diet as potential cause of prostatic diseases

Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplsia, prostatitis, and prostate cancer.

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

UCLA plans nanotechnology collaboration with Hamamatsu Photonics

The California NanoSystems Institute at UCLA has announced plans to collaborate with Hamamatsu Photonics Corp., a leading developer and manufacturer of photon detectors and camera systems, to apply nanoscience and nanotechnology to projects having global importance in health, medicine, energy and the environment.

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Mount Sinai researchers coordinating the largest clinical study to date of "Sarcoid Like" Granulomatous Pulmonary Disease in World Trade Center (WTC) responders have found that the rate of the condition was increased in this group as compared to the records of pre-9/11 FDNY personnel. The study is published online in the American Journal of Industrial Medicine.

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).

Sage View Care Center - in Rock Springs, WY